Clinical Trial

A Study to Test How BI 1819479 is Taken up and Processed by the Body

Terminated Phase 1
View on ClinicalTrials.gov →
Why the trial stopped
Company decision
Summary
This trial is intended to investigate the mass balance, metabolism, and basic pharmacokinetics of BI 1819479 (C-14) (Part A) and to investigate the absolute bioavailability of BI 1819479 (Part B) in healthy male volunteers.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2025-07-04; most recent amendment 2026-03-16.
Status change: Active, Not Recruiting → Terminated 2025-12-01
Status change: Recruiting → Active, Not Recruiting 2025-11-27
Status change: Not Yet Recruiting → Recruiting 2025-08-07
Trial Details
NCT Number NCT07065617
Lead Sponsor Boehringer Ingelheim
Conditions Healthy
Enrollment 7 participants
Start Date 2025-08-04
Primary Completion 2025-10-04 (estimated)
Study Completion 2025-11-04 (estimated)
Updated on ClinicalTrials.gov 2026-03-17